SHAN, JOSEPH S.,KALLINTERIS, NIKOLETTA L.,TANG, MIN,DORR, ANDREW F.
申请号：
CA3055769
公开号：
CA3055769A1
申请日:
2018.04.02
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Disclosed are methods and kits for treating patients, particularly cancer patients, using bavituximab in combination therapies with immuno-oncology (IO) agents such as checkpoint inhibitor antibodies. The methods and kits are based on the surprising finding that human patients treated with bavituximab and checkpoint inhibitor antibodies have a statistically significant prolonged survival in controlled studies.
